These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29783009)

  • 1. Antiplatelet Medication Reversal Strategies in Operative Intracranial Hemorrhage: A Survey of Practicing Neurosurgeons.
    Foreman PM; Ilyas A; Mooney J; Schmalz PGR; Walters BC; Griessenauer CJ
    World Neurosurg; 2018 Aug; 116():e649-e654. PubMed ID: 29783009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Administration of Desmopressin and Platelet Transfusion for Reducing Hematoma Expansion in Patients With Acute Antiplatelet Therapy Associated Intracerebral Hemorrhage.
    Mengel A; Stefanou MI; Hadaschik KA; Wolf M; Stadler V; Poli K; Lindig T; Ernemann U; Grimm F; Tatagiba M; Ziemann U; Poli S
    Crit Care Med; 2020 Jul; 48(7):1009-1017. PubMed ID: 32304415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review.
    Campbell PG; Sen A; Yadla S; Jabbour P; Jallo J
    World Neurosurg; 2010; 74(2-3):279-85. PubMed ID: 21492561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of antiplatelet therapy in traumatic intracranial hemorrhage: Does timing matter?
    Pandya U; Malik A; Messina M; Albeiruti AR; Spalding C
    J Clin Neurosci; 2018 Apr; 50():88-92. PubMed ID: 29452965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a TEG-Platelet Mapping Algorithm to Guide Reversal of Antiplatelet Agents in Adults with Mild-to-Moderate Traumatic Brain Injury: An Observational Pilot Study.
    Kvint S; Gutierrez A; Venezia A; Maloney E; Schuster J; Kumar MA
    Neurocrit Care; 2022 Dec; 37(3):638-648. PubMed ID: 35705826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cohort analysis of desmopressin effect on hematoma expansion in patients with spontaneous intracerebral hemorrhage and documented pre-ictus antiplatelet use.
    Schmidt KJ; Sager B; Zachariah J; Raad BF; James EG; Fletcher JJ
    J Clin Neurosci; 2019 Aug; 66():33-37. PubMed ID: 31160199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Desmopressin on Hematoma Expansion in Patients with Mild Traumatic Brain Injury Prescribed Pre-injury Antiplatelet Medications.
    Barletta JF; Abdul-Rahman D; Hall ST; Mangram AJ; Dzandu JK; Frontera JA; Zach V
    Neurocrit Care; 2020 Oct; 33(2):405-413. PubMed ID: 31898177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of desmopressin acetate on acute spontaneous intracranial hemorrhage in patients on antiplatelet therapy.
    McManus J; Ferreira J; Jones GM; Smetana KS; Smith Condeni M; Berger K; Witenko C; Smotherman C; Gautam S; Pizzi MA; Erdman MJ
    J Neurol Sci; 2022 Mar; 434():120142. PubMed ID: 35081458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of platelet transfusion in the management of acute subdural hematoma.
    Ogunlade J; Wiginton JG; Ghanchi H; Al-Atrache Z; Wacker M; Menoni R; Miulli D
    Clin Neurol Neurosurg; 2018 Nov; 174():163-166. PubMed ID: 30245434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Assessment of Desmopressin Effectiveness and Safety in Patients With Antiplatelet-Associated Intracranial Hemorrhage.
    Feldman EA; Meola G; Zyck S; Miller CD; Krishnamurthy S; Cwikla GM; Darko W; Jennings S; Sullivan R; Seabury R
    Crit Care Med; 2019 Dec; 47(12):1759-1765. PubMed ID: 31567345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet Medication and Operative Subdural Hematomas: A Retrospective Cohort Study Evaluating Reoperation Rates.
    Foreman PM; Mooney J; Ilyas A; Agee B; Vivekanandan S; Fong RP; Okor MO; Riley KO; Griessenauer CJ
    World Neurosurg; 2019 May; 125():e671-e677. PubMed ID: 30735874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin for Antiplatelet-Associated Intracranial Hemorrhage: A Concise Review.
    Geiger H; Samai K
    J Trauma Nurs; 2021 Jan-Mar 01; 28(1):56-58. PubMed ID: 33417404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.
    Frontera JA; Lewin JJ; Rabinstein AA; Aisiku IP; Alexandrov AW; Cook AM; del Zoppo GJ; Kumar MA; Peerschke EI; Stiefel MF; Teitelbaum JS; Wartenberg KE; Zerfoss CL
    Neurocrit Care; 2016 Feb; 24(1):6-46. PubMed ID: 26714677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal and Resumption of Antithrombotic Therapy in LVAD-Associated Intracranial Hemorrhage.
    Cho SM; Moazami N; Katz S; Starling R; Frontera JA
    Ann Thorac Surg; 2019 Jul; 108(1):52-58. PubMed ID: 30763560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter retrospective study evaluating the impact of desmopressin on hematoma expansion in patients with antiplatelet-associated intracranial hemorrhage.
    Summers A; Singh J; Lai M; Schomer KJ; Martin R; Vitt JR; Derry KL; Box K; Chu F; Arias V; Minokadeh A; Stern-Nezer S; Groysman L; Lee BJ; Atallah S
    Thromb Res; 2023 Feb; 222():96-101. PubMed ID: 36610266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter study of DDAVP versus platelet transfusions for antiplatelet agent reversal in patients with traumatic brain injury.
    Westfall KM; Andrews J; Sadek E; Curtiss W; Hecht J
    Neurol Sci; 2024 Jul; 45(7):3325-3332. PubMed ID: 38353847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Desmopressin on Platelet Dysfunction During Antiplatelet Therapy: A Systematic Review.
    Andersen LK; Hvas AM; Hvas CL
    Neurocrit Care; 2021 Jun; 34(3):1026-1046. PubMed ID: 32748210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of anticoagulants, antiplatelet agents, and their reversal strategies in the management of intracerebral hemorrhage.
    James RF; Palys V; Lomboy JR; Lamm JR; Simon SD
    Neurosurg Focus; 2013 May; 34(5):E6. PubMed ID: 23634925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Aneurysmal Subarachnoid Hemorrhage Patients with Antiplatelet Use Before the Initial Hemorrhage: An International Survey.
    Sebök M; Keller E; van Niftrik CHB; Regli L; Germans MR
    World Neurosurg; 2018 Dec; 120():e408-e413. PubMed ID: 30149168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of hemorrhagic complication associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on dual antiplatelet therapy.
    Mahaney KB; Chalouhi N; Viljoen S; Smietana J; Kung DK; Jabbour P; Bulsara KR; Howard M; Hasan DM
    J Neurosurg; 2013 Oct; 119(4):937-42. PubMed ID: 23808537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.